UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Social Distancing, Lockdown and the Wide Use of Mask; A Magic Solution or a Double-Edged Sword for Respiratory Viruses Epidemiology?

Vaccines (Basel), 2021-06, Vol.9 (6), p.595

2021

Volltextzugriff (PDF)

CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses?

Pharmaceuticals (Basel, Switzerland), 2021-12, Vol.15 (1), p.32

2021

Volltextzugriff (PDF)

InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection

Cephalalgia, 2023-11, Vol.43 (11), p.3331024231212900-3331024231212900

2023

Volltextzugriff (PDF)

Association of viral loads of influenza A (H3N2) with age and care setting on presentation—a prospective study during the 2022-2023 influenza season in Spain

International journal of infectious diseases, 2024-06, Vol.143, p.107034, Article 107034

2024

Volltextzugriff (PDF)

Adjuvants for COVID-19 Vaccines

Vaccines (Basel), 2023-04, Vol.11 (5), p.902

2023

Volltextzugriff (PDF)

Group 1 and group 2 hemagglutinin stalk antibody response according to age

Frontiers in immunology, 2023-05, Vol.14, p.1194073-1194073

2023

Volltextzugriff (PDF)

Do Vaccines Need a Gender Perspective? Influenza Says Yes

Frontiers in immunology, 2021-07, Vol.12, p.715688-715688

2021

Volltextzugriff (PDF)

Immunodominance hierarchy after seasonal influenza vaccination

Emerging microbes & infections, 2022-12, Vol.11 (1), p.2670-2679

2022

Volltextzugriff (PDF)

Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses

Frontiers in microbiology, 2021-11, Vol.12, p.737216-737216

2021

Volltextzugriff (PDF)

Incidence and prevalence of headache in influenza: A 2010–2021 surveillance‐based study

European journal of neurology, 2024-08, Vol.31 (8), p.e16349-n/a

2024

Volltextzugriff (PDF)

The Impact of the COVID-19 Pandemic on Influenza Vaccination Attitudes and Actions in Spain’s Adult Population

Vaccines (Basel), 2023-09, Vol.11 (10), p.1514

2023

Volltextzugriff (PDF)

Impact of COVID-19 on Adherence to Treatment in Patients with HIV

Healthcare (Basel), 2023-05, Vol.11 (9), p.1299

2023

Volltextzugriff (PDF)

Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older Adults

Emerging infectious diseases, 2023-03, Vol.29 (3), p.656-658

2023

Volltextzugriff (PDF)

Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection

Scientific reports, 2024-01, Vol.14 (1), p.353-353, Article 353

2024

Volltextzugriff (PDF)

PCR-based diagnosis of respiratory virus in postsurgical septic patients: A preliminary study before SARS-CoV-2 pandemic

Medicine (Baltimore), 2022-08, Vol.101 (32), p.e29902

2022

Volltextzugriff (PDF)

Corrigendum: Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept

Frontiers in immunology, 2024-07, Vol.15, p.1447503

2024

Volltextzugriff (PDF)

Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept

Frontiers in immunology, 2022-07, Vol.13, p.918887

2022

Volltextzugriff (PDF)

Attitudes, Perceptions and Practices of Influenza Vaccination in the Adult Population: Results of a Cross-Sectional Survey in Spain

International journal of environmental research and public health, 2022-09, Vol.19 (17), p.11139

2022

Volltextzugriff (PDF)

Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study

Journal of headache and pain, 2024-02, Vol.25 (1), p.18-18, Article 18

2024

Volltextzugriff (PDF)

Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people

Frontiers in immunology, 2023-02, Vol.14, p.1128302-1128302

2023

Volltextzugriff (PDF)

RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

Infectious diseases and therapy, 2024-09, Vol.13 (9), p.1983-1999

2024

Volltextzugriff (PDF)

Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults

Human vaccines & immunotherapeutics, 2023-08, Vol.19 (2), p.2236537-2236537

2023

Volltextzugriff (PDF)

Microbiological and epidemiological features of respiratory syncytial virus

Revista española de quimioterapia, 2024-06, Vol.37 (3), p.209-220

2024

Volltextzugriff (PDF)

Potential Effects on Elderly People From Nirsevimab Use in Infants

Open respiratory archives, 2024-04, Vol.6 (2), p.100320-100320, Article 100320

2024

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(52)

Sprache

Englisch
(44)
Spanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Social Distancing, Lockdown and the Wide Use of Mask; A Magic Solution or a Double-Edged Sword for Respiratory Viruses Epidemiology?

CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses?

InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection

Association of viral loads of influenza A (H3N2) with age and care setting on presentation—a prospective study during the 2022-2023 influenza season in Spain

Adjuvants for COVID-19 Vaccines

Group 1 and group 2 hemagglutinin stalk antibody response according to age

Do Vaccines Need a Gender Perspective? Influenza Says Yes

Immunodominance hierarchy after seasonal influenza vaccination

Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses

Incidence and prevalence of headache in influenza: A 2010–2021 surveillance‐based study

The Impact of the COVID-19 Pandemic on Influenza Vaccination Attitudes and Actions in Spain’s Adult Population

Impact of COVID-19 on Adherence to Treatment in Patients with HIV

Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older Adults

Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection

PCR-based diagnosis of respiratory virus in postsurgical septic patients: A preliminary study before SARS-CoV-2 pandemic

Corrigendum: Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept

Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial

Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept

Attitudes, Perceptions and Practices of Influenza Vaccination in the Adult Population: Results of a Cross-Sectional Survey in Spain

Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study

Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people

RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults

Microbiological and epidemiological features of respiratory syncytial virus

Potential Effects on Elderly People From Nirsevimab Use in Infants

Suchergebnisse filtern